Link to this page
The Prescription of Drugs Ontology
| Preferred Name | Ticagrelor | |
| Synonyms |
(1S,2S,3R,5S)-3-(7-((1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino)-5-(propylthio)-3H-(1,2,3)triazolo(4,5-d)pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol AZD 6140 AZD-6140 AZD6140 Brilinta ticagrelor (1S,2S,3R,5S)-3-[7-{[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino}-5-(propylsulfanyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
|
| Definitions |
A triazolopyrimidine that is an adenosine isostere; the cyclopentane ring is similar to ribose and the nitrogen-rich [1,2,3]triazolo[4,5-d]pyrimidine moiety resembles the nucleobase adenine. A platelet aggregation inhibitor which is used for prevention of thromboembolic events in patients with acute coronary syndrome. |
|
| ID |
http://purl.obolibrary.org/obo/CHEBI_68558 |
|
| alternative term |
(1S,2S,3R,5S)-3-(7-((1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino)-5-(propylthio)-3H-(1,2,3)triazolo(4,5-d)pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol AZD 6140 AZD-6140 AZD6140 Brilinta ticagrelor (1S,2S,3R,5S)-3-[7-{[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino}-5-(propylsulfanyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
|
|
| bearer_of | ||
| charge |
0
|
|
| database_cross_reference |
Drug_Central:4184 PMID:22991347 KEGG:D09017 HMDB:HMDB0015702 Reaxys:15468079 CAS:274693-27-5 Patent:WO2012085665
|
|
| formula |
C23H28F2N6O4S
|
|
| has role | ||
| has_exact_synonym |
(1S,2S,3R,5S)-3-[7-{[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino}-5-(propylsulfanyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
|
|
| has_obo_namespace |
chebi_ontology
|
|
| has_related_synonym |
(1S,2S,3R,5S)-3-(7-((1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino)-5-(propylthio)-3H-(1,2,3)triazolo(4,5-d)pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol AZD 6140 AZD-6140 AZD6140 Brilinta ticagrelor
|
|
| has_RxCUI |
1116632
|
|
| id |
CHEBI:68558
|
|
| in_subset | ||
| inchi |
InChI=1S/C23H28F2N6O4S/c1-2-7-36-23-27-21(26-15-9-12(15)11-3-4-13(24)14(25)8-11)18-22(28-23)31(30-29-18)16-10-17(35-6-5-32)20(34)19(16)33/h3-4,8,12,15-17,19-20,32-34H,2,5-7,9-10H2,1H3,(H,26,27,28)/t12-,15+,16+,17-,19-,20+/m0/s1
|
|
| inchikey |
OEKWJQXRCDYSHL-FNOIDJSQSA-N
|
|
| label |
ticagrelor Ticagrelor
|
|
| mass |
522.56800
|
|
| monoisotopicmass |
522.18608
|
|
| notation |
CHEBI:68558
|
|
| prefixIRI |
CHEBI:68558
|
|
| prefLabel |
Ticagrelor
|
|
| smiles |
CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1
|
|
| textual definition |
A triazolopyrimidine that is an adenosine isostere; the cyclopentane ring is similar to ribose and the nitrogen-rich [1,2,3]triazolo[4,5-d]pyrimidine moiety resembles the nucleobase adenine. A platelet aggregation inhibitor which is used for prevention of thromboembolic events in patients with acute coronary syndrome.
|
|
| subClassOf |
http://purl.obolibrary.org/obo/CHEBI_50995 http://purl.obolibrary.org/obo/CHEBI_37143 http://purl.obolibrary.org/obo/CHEBI_35683 |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |